Compare ACGL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACGL | GEHC |
|---|---|---|
| Founded | 2001 | 1892 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 29.1B |
| IPO Year | 1996 | 2022 |
| Metric | ACGL | GEHC |
|---|---|---|
| Price | $101.10 | $69.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 21 |
| Target Price | ★ $110.13 | $82.70 |
| AVG Volume (30 Days) | 3.2M | ★ 3.5M |
| Earning Date | 10-27-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | 3.66 | ★ 4.84 |
| EPS | ★ 5.88 | 0.85 |
| Revenue | $19,929,000,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | N/A | $5.32 |
| Revenue Next Year | $0.08 | $4.60 |
| P/E Ratio | ★ $16.88 | $82.82 |
| Revenue Growth | ★ 14.27 | 4.84 |
| 52 Week Low | $82.45 | $58.75 |
| 52 Week High | $107.09 | $89.77 |
| Indicator | ACGL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 67.70 | 61.48 |
| Support Level | $97.48 | $68.88 |
| Resistance Level | $101.72 | $72.77 |
| Average True Range (ATR) | 1.67 | 1.62 |
| MACD | 0.77 | 0.71 |
| Stochastic Oscillator | 98.98 | 79.89 |
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).